中国药物经济学2019，Vol.14Issue(1)：21-25,5.DOI:10.12010/j.issn.1673-5846.2019.01.004
中国呼吸系统疾病药物利用现状:基于3个数据库比较分析
Current Drug Utilization of Respiratory System Disease in China: A Comparative Analysis Based on 3 Databases
摘要
Abstract
Objectives To explore the current drug utilization of respiratory system disease in China through empirical analysis of data on hospital respiratory system medications in different channels. Methods The drug utilization data of respiratory system disease in hospitals were obtained from three different Chinese pharmaceutical market databases (CHIS database, PDB database and MENET database). Excel software was used to collate and analyze the data, and to understand the drug utilization of respiratory system disease in China. Results CHIS data analysis based on multi-channel data found that the overall growth of the use of drugs for respiratory system diseases, mainly cough and cold preparations, had slowed down. PDB data analysis based on major urban hospital channels found that the use of drugs for respiratory system diseases, mainly antiasthmatic drugs, had increased rapidly; MENET data analysis based on public hospital channels in key cities found that drugs for respiratory system diseases in public hospital had become the biggest growth area. Conclusion Drug use for respiratory diseases in China is on the rise as a whole, but the growth is different in different channels.关键词
药物利用/呼吸系统疾病/CHIS数据库/PDB数据库/MENET数据库Key words
Drug utilization/Respiratory system disease/CHIS database/PDB database/MENET database分类
医药卫生引用本文复制引用
赖云锋,陈献文,陈圣琦,郭琰,别瑞雪,韩晟,史录文,胡豪..中国呼吸系统疾病药物利用现状:基于3个数据库比较分析[J].中国药物经济学,2019,14(1):21-25,5.基金项目
国家自然科学基金青年项目(71603008,基于非随机指数理论模型的中国医院药品费用增长构成研究) （71603008,基于非随机指数理论模型的中国医院药品费用增长构成研究）
澳门大学研究委员会课题(MYRG2018-00012-ICMS) （MYRG2018-00012-ICMS）
